Architectural firm TRIA announced the completion of Korro Bio’s new headquarters in Cambridge, MA. The office and laboratory fit-out spans 50,000 square feet and marks a significant milestone for the biopharmaceutical company developing RNA-based genetic medicines. It was completed ahead of schedule and under budget.

Korro Bio, which specializes in developing therapies for patients with both rare and highly prevalent diseases, sought a space that would reflect its mission and accommodate its growth. The new headquarters includes open, flexible work environments, dynamic meeting hubs, and lab spaces designed to foster creativity and scientific discovery.

“This project was a fantastic collaboration between Korro Bio’s leadership and our design team,” said Amanda Roderman, project manager at Boston-based TRIA. “Our goal was to design an environment that reflects Korro Bio’s cutting-edge work in the biopharmaceutical field while offering employees a comfortable, dynamic place to thrive.”

Inspirna, Inc., a clinical stage biopharmaceutical company developing cancer therapeutics, is relocating its offices from Manhattan to the outer boroughs. The firm has inked a 7,302-square-foot office sublease at the Alexandria Center for Life Science, located at 30-02 48th Ave. in Long Island City, NY. Inspirna will relocate and expand its offices and lab space from the NY Blood Center Building at 310 E. 67th St. on Manhattan’s Upper East Side to space previously occupied by an affiliate of Opentrons.

CBRE’s Joseph DeRosa and John Isaacs represented Inspirna in the sublease negotiations.

“Inspirna was looking for a better location and to expand to a dedicated life science ecosystem,” said DeRosa. “After a thorough market analysis, we were able to secure a significantly below market sublease for our client in a first-class life science property.” 

Isaacs added, “The Alexandria Center for Life Science is ideally located to serve its employee base, and also provides specific scientific amenities that are critical to Inspirna’s business operations, which only a few buildings in New York City currently offer.”